About
Director since July 2020. Former EVP of Finance and Strategy of Royalty Pharma Management. Serves on the boards of AnaptysBio, Theravance Biopharma and Maravai LifeSciences.
Roles
4D Molecular Therapeutics, Inc.
Director · Current role
2020–present
Director Compensation
FY 2025
Fees earned or paid in cash
$65,000
Also at 4D Molecular Therapeutics, Inc.